The employee and medical screening specialist said the service will provide employees with a CRL Clear kit to test blood samples for coronavirus antibodies which will indicate if a person has been previously infected with the disease.
WATCH: ClearStar reveals increased revenue numbers driven by new types of screening, medical service demand
If the employee tests positive, they will then receive a CRL Rapid Response kit, a saliva-based molecular diagnostic test to determine if the virus is still active. A positive test, in this case, indicates the employee is still infected with coronavirus and will automatically be contacted by a doctor to discuss the results and next steps.
ClearStar said its customers will be able to order the tests using its existing drug and clinical screening programmes, with test results to be reported via the firm’s platform within 24 hours of samples being received by the Clinical Reference Laboratory in the US.
"Balancing the equally important goals of getting people back to work and ensuring their safety and well-being is top priority for employers. We are proud to be able to offer our customers a new [coronavirus] testing service, and by partnering with Clinical Reference Laboratory, whose tests are easy to self-administer, we can offer a reliable and quick turnaround”, ClearStar chief executive Robert Vale said in a statement.
“This new service - alongside our existing suite of background and medical screening solutions - will help employers to make more informed hiring and return-to-work decisions to get people into work quicker while maintaining public safety", he added.